Vol 81, No 5 (2023)
Clinical vignette
Published online: 2023-03-29

open access

Page views 1715
Article views/downloads 298
Get Citation

Connect on Social Media

Connect on Social Media

Rescue balloon aortic valvuloplasty in a patient with cardiogenic shock followed by transcatheter aortic valve implantation

Łukasz Niewiara12, Rafał Badacz23, Jarosław Trębacz2, Anna Kabłak-Ziembicka23, Maciej Stąpór2, Janusz Konstanty-Kalandyk45, Michał Okarski6, Krystian Mróz6, Jacek Legutko23, Paweł Kleczyński23
Pubmed: 36999727
Kardiol Pol 2023;81(5):533-534.

Abstract

Not available

Clinical vignette

Rescue balloon aortic valvuloplasty in a patient with cardiogenic shock followed by transcatheter aortic valve implantation

Łukasz Niewiara12Rafał Badacz23Jarosław Trębacz2Anna Kabłak-Ziembicka23Maciej Stąpór2Janusz Konstanty-Kalandyk45Michał Okarski6Krystian Mróz6Jacek Legutko23Paweł Kleczyński23
1Department of Emergency Medicine, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland
2Clinical Department of Interventional Cardiology, John Paul II Hospital, Kraków, Poland
3Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland
4Clinical Department of Cardiac Surgery and Transplantation, John Paul II Hospital, Kraków, Poland
5Jagiellonian University Medical College, Institute of Cardiology, Department of Cardiac Surgery and Transplantation, John Paul II Hospital, Kraków, Poland
6Student Scientific Group of Modern Cardiac Therapy at the Department of Interventional Cardiology, Jagiellonian University Medical College, Kraków, Poland

Correspondence to:

Paweł Kleczyński, MD, PhD, FESC,

Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital,

Prądnicka 80, 31–202 Kraków, Poland,

phone: +48 12 614 35 01,

e-mail: kleczu@interia.pl

Copyright by the Author(s), 2023

DOI: 10.33963/KP.a2023.0083

Received: January 5, 2023

Accepted: March 19, 2023

Early publication date: March 29, 2023

Balloon aortic valvuloplasty (BAV) is a technique for the treatment of severe aortic valve stenosis (AS) which is used less frequently in contemporary practice; however, according to the current ESC guidelines, it still may be considered a bridge to further therapy in decompensated patients [1, 2]. Recently published data suggest that over half of the procedures may be performed as a bailout strategy [3].

A 71-year-old male with a history of arterial hypertension, chronic obstructive pulmonary disease, and paroxysmal atrial fibrillation was admitted for evaluation of his AS. Moreover, he was diagnosed with advanced coxarthrosis and required walking assistance. The patient was symptomatic, in class II/III according to the New York Heart Association (NYHA) classification; however, no signs of decompensation were present on admission. Transthoracic echocardiography (Figure 1A) confirmed severe AS with mean gradient of 58 mm Hg and aortic valve area (AVA) of 0.3 cm2 with mildly reduced left ventricular ejection fraction (40%). Immediately after non-invasive testing on the same day, the patient developed severe dyspnea, hypotonia, and finally, cardiogenic shock within several minutes.

Figure 1. A. Baseline transthoracic echocardiography showing severe aortic valve stenosis. B. Coronary angiography of the left coronary system with no significant lesions. C. Coronary angiography of the right coronary artery with a moderate lesion in its proximal segment. D1. A 9.0 × 50 mm peripheral angioplasty balloon that passed across the stenosed valve. D2. The final 22 × 50 mm valvuloplasty balloon (white arrows calcifications). E. Computed tomography angiography assessment showing optimal femoral access. F. Self-expanding aortic valve implantation

Due to pulmonary edema with low blood pressure, the patient was intubated and mechanically ventilated. An urgent remote Heart Team assessment was performed, and the patient was qualified for coronary angiography with concomitant rescue BAV. The coronary angiogram revealed no significant coronary lesions (Figures 1B and 1C). Due to severe calcifications of leaflets, a 22 mm Osypka VACS II (Osypka, Rheinfelden, Germany) balloon was unable to cross the aortic valve so additional predilatation with 8.0 × 50 mm and 9.0 × 50 mm (Figure 1D1) peripheral balloon catheters was performed. Eventually, a 22 × 50 mm balloon catheter was successfully introduced and BAV was performed (Figure 1D2). Periprocedural echocardiography confirmed a decrease in mean gradient to 38 mm Hg with AVA of 1.0 cm2. Pre-transcatheter aortic valve implantation (TAVI) was abandoned at the time due to unknown neurological status of the patient. The patient was hospitalized in the intensive care unit for 2 days. After his recovery, additional imaging with computed tomography, according to the TAVI workup, was performed to assess the valve and vascular access (Figure 1E). Within a week, a TAVI procedure was performed (Figure 1F) using a self-expanding Navitor 25 valve (Abbott, Chicago, IL, US). Post-procedural echocardiography showed 9/5 mmHg gradient and mild perivalvular leak. The patient was successfully discharged home after 16 days of in-hospital treatment. He attended the 30-day follow-up appointment alone, with almost no signs of physical and mental decline.

Symptomatic severe AS is still a life-threatening condition. Balloon aortic valvuloplasty remains a feasible method that can be used as a bridge-to-therapy as well as a bailout strategy in critical cases and followed by definite treatment [4].

Article information

Conflict of interest: None declared.

Funding: None.

Open access: This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, which allows downloading and sharing articles with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. For commercial use, please contact the journal office at kardiologiapolska@ptkardio.pl.

REFERENCES

  1. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561632, doi: 10.1093/eurheartj/ehab395, indexed in Pubmed: 34453165.
  2. Kleczynski P, Kulbat A, Brzychczy P, et al. Balloon aortic valvuloplasty for severe aortic stenosis as rescue or bridge therapy. J Clin Med. 2021; 10(20), doi: 10.3390/jcm10204657, indexed in Pubmed: 34682783.
  3. Tyczyński P, Chmielak Z, Dąbrowski M, et al. Elective versus rescue balloon aortic valvuloplasty for critical aortic stenosis. Kardiol Pol. 2020; 78(10): 982989, doi: 10.33963/KP.15299, indexed in Pubmed: 32329317.
  4. Kleczynski P, Brzychczy P, Kulbat A, et al. Balloon aortic valvuloplasty for severe aortic stenosis may reduce mitral regurgitation in mid-term follow-up. Postepy Kardiol Interwencyjnej. 2022; 18(3): 255260, doi: 10.5114/aic.2022.121004, indexed in Pubmed: 36751280.



Polish Heart Journal (Kardiologia Polska)